Equity

Share Repurchase Authorization Limit

Eli Lilly Share Repurchase Authorization Limit remained flat by 0.0% to $15.00B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 657.6%, from $1.98B to $15.00B. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementBalance Sheet Statement
SectionEquity
CategoryCapital Allocation
SignalHigher is better
VolatilityModerate
First reportedQ3 2016
Last reportedQ3 2025

How to read this metric

An increase suggests management believes the stock is undervalued or that they have excess cash to return to investors.

Detailed definition

This is the total dollar amount approved by the board of directors for the company to buy back its own common stock from...

Peer comparison

Commonly disclosed by large-cap companies as part of their capital return strategy.

Metric ID: share_repurchase_authorization_limit

Historical Data

14 periods
 Q2 '21Q3 '21Q1 '22Q2 '22Q3 '22Q1 '23Q2 '23Q3 '23Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25
Value$5.00B$500.00M$3.25B$3.25B$3.25B$2.50B$2.50B$2.50B$2.50B$2.50B$1.98B$15.00B$15.00B$15.00B
QoQ Change-90.0%+550.0%+0.0%+0.0%-23.1%+0.0%+0.0%+0.0%+0.0%-20.8%+657.6%+0.0%+0.0%
YoY Change-35.0%+550.0%-23.1%-23.1%-23.1%+0.0%+0.0%-20.8%+500.0%+500.0%+657.6%
Range$500.00M$15.00B
CAGR+40.2%
Avg YoY Growth+189.3%
Median YoY Growth+0.0%
Current Streak3 quarters growth

Frequently Asked Questions

What is Eli Lilly's share repurchase authorization limit?
Eli Lilly (LLY) reported share repurchase authorization limit of $15.00B in Q3 2025.
How has Eli Lilly's share repurchase authorization limit changed year-over-year?
Eli Lilly's share repurchase authorization limit increased by 657.6% year-over-year, from $1.98B to $15.00B.
What does share repurchase authorization limit mean?
The maximum dollar amount the board has approved for buying back company shares.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.